3,000 Shares in Colgate-Palmolive Company $CL Acquired by HighMark Wealth Management LLC

HighMark Wealth Management LLC bought a new position in shares of Colgate-Palmolive Company (NYSE:CL) in the 2nd quarter, HoldingsChannel.com reports. The fund bought 3,000 shares of the company’s stock, valued at approximately $273,000.

Other large investors have also modified their holdings of the company. Brighton Jones LLC boosted its stake in Colgate-Palmolive by 4.4% during the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock worth $962,000 after buying an additional 450 shares during the period. NBC Securities Inc. lifted its holdings in shares of Colgate-Palmolive by 112,160.0% in the 1st quarter. NBC Securities Inc. now owns 5,613 shares of the company’s stock worth $525,000 after acquiring an additional 5,608 shares during the last quarter. Merit Financial Group LLC boosted its position in shares of Colgate-Palmolive by 13.6% during the 1st quarter. Merit Financial Group LLC now owns 34,809 shares of the company’s stock worth $3,262,000 after purchasing an additional 4,169 shares during the period. RFG Advisory LLC increased its holdings in Colgate-Palmolive by 85.6% in the 1st quarter. RFG Advisory LLC now owns 9,104 shares of the company’s stock valued at $853,000 after purchasing an additional 4,199 shares during the last quarter. Finally, Hennion & Walsh Asset Management Inc. raised its position in Colgate-Palmolive by 1.7% in the first quarter. Hennion & Walsh Asset Management Inc. now owns 21,699 shares of the company’s stock valued at $2,033,000 after purchasing an additional 357 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Stock Down 0.9%

Colgate-Palmolive stock opened at $78.30 on Friday. The stock has a market cap of $63.28 billion, a PE ratio of 21.99, a P/E/G ratio of 4.11 and a beta of 0.34. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57. The stock’s fifty day moving average is $83.49 and its two-hundred day moving average is $88.41. Colgate-Palmolive Company has a 1-year low of $78.18 and a 1-year high of $102.61.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, August 1st. The company reported $0.92 EPS for the quarter, beating analysts’ consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The business had revenue of $5.11 billion for the quarter, compared to the consensus estimate of $5.03 billion. During the same quarter in the prior year, the business posted $0.91 EPS. The business’s revenue for the quarter was up 1.0% on a year-over-year basis. On average, sell-side analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 17th will be issued a dividend of $0.52 per share. The ex-dividend date of this dividend is Friday, October 17th. This represents a $2.08 dividend on an annualized basis and a yield of 2.7%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 58.43%.

Analyst Ratings Changes

Several research analysts have recently commented on the company. UBS Group lowered their price target on Colgate-Palmolive from $109.00 to $106.00 and set a “buy” rating for the company in a research report on Thursday, July 17th. Citigroup decreased their target price on Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating on the stock in a research note on Monday, August 4th. Barclays dropped their target price on Colgate-Palmolive from $87.00 to $82.00 and set an “equal weight” rating for the company in a research report on Wednesday. JPMorgan Chase & Co. reduced their price target on shares of Colgate-Palmolive from $99.00 to $95.00 and set an “overweight” rating on the stock in a research report on Monday, August 4th. Finally, Wells Fargo & Company dropped their price objective on shares of Colgate-Palmolive from $83.00 to $80.00 and set an “underweight” rating for the company in a report on Thursday, September 25th. Eight investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Colgate-Palmolive currently has an average rating of “Moderate Buy” and a consensus price target of $96.75.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.